Mirae Asset Global ETFs Holdings’s Pacific Biosciences PACB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$742K	Buy	441,639 +105,382	+31%	+$153K	﹤0.01%	1790
2026 Q1	$444K	Buy	336,257 +11,118	+3%	+$19.9K	﹤0.01%	1945
2025 Q4	$608K	Sell	325,139 -11	-0%	-$21	﹤0.01%	1791
2025 Q3	$416K	Sell	325,150 -25,398	-7%	-$34.4K	﹤0.01%	1950
2025 Q2	$435K	Sell	350,548 -338,978	-49%	-$391K	﹤0.01%	1891
2025 Q1	$814K	Sell	689,526 -14,435	-2%	-$22.1K	﹤0.01%	1597
2024 Q4	$1.29M	Sell	703,961 -28,506	-4%	-$55.6K	﹤0.01%	1414
2024 Q3	$1.25M	Sell	732,467 -86,435	-11%	-$142K	﹤0.01%	1421
2024 Q2	$1.12M	Buy	+818,902	New	+$1.65M	﹤0.01%	1392

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PACB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Pacific Biosciences (PACB) stake by 31% in Q2 2026, buying an estimated $153K and bringing the position to 441,639 shares worth $742K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Mirae Asset Global ETFs Holdings first reported a position in PACB in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.29M in Q4 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Mirae Asset Global ETFs Holdings held 441,639 shares of Pacific Biosciences worth $742K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 105,382 Pacific Biosciences shares in Q2 2026, an estimated $153K.
Pacific Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1790 holding.
Mirae Asset Global ETFs Holdings first reported a position in Pacific Biosciences in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Pacific Biosciences position peaked at $1.29M in Q4 2024.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.